InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,318.84
(
-0.90%
)
Post# of 48
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Steveg

Send PM Follow Ignore
Followers 2
Posts 440
Boards Moderated 0
Alias Born 02/25/2004

Steveg

Re: drdata post# 22

Friday, 10/13/2006 8:57:03 PM

Friday, October 13, 2006 8:57:03 PM

Post# of 48
drdata: I don't know the answer. The dilution is significant. Taking advantage of the rights offering allows a shareholder to offset it. You do the math. I hope that the restructured and refinanced company will be able to renew its quest to achieve a significant licensing agreement or joint venture. I understand that the company will visit or re-visit the candidates. No one questions the value of the patents or the science. It is an issue of making and completing an agreement.

Steve
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up